Patents by Inventor Edward John Zambraski

Edward John Zambraski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7867983
    Abstract: Disclosed herein are compositions and methods for the treatment of skeletal muscle and/or the protection of skeletal muscle against injury. The adenosine A3 receptor has been identified as a new therapeutic target for the treatment of skeletal muscle. Adenosine A3 receptor agonists are used treat subjects with skeletal muscle ischemia and reperfusion (I/R) injuries, individuals with skeletal muscle disorders, and individuals suffering from skeletal muscle injury resulting from physical exertion.
    Type: Grant
    Filed: March 25, 2008
    Date of Patent: January 11, 2011
    Assignees: The University of Connecticut, The United States of America as represented by the Secretary of the Army
    Inventors: Bruce Tsan-Tang Liang, Edward John Zambraski
  • Publication number: 20080312180
    Abstract: Disclosed herein are compositions and methods for the treatment of skeletal muscle and/or the protection of skeletal muscle against injury. The adenosine A3 receptor has been identified as a new therapeutic target for the treatment of skeletal muscle. Adenosine A3 receptor agonists are used treat subjects with skeletal muscle ischemia and reperfusion (I/R) injuries, individuals with skeletal muscle disorders, and individuals suffering from skeletal muscle injury resulting from physical exertion.
    Type: Application
    Filed: March 25, 2008
    Publication date: December 18, 2008
    Applicants: Institute of Enviromental Medicine
    Inventors: Bruce Tsan-Tang Liang, Edward John Zambraski